Virobay Inc
Virobay Inc., based in Menlo Park, CA, specializes in the discovery and development of protease inhibitors aimed at treating a variety of conditions, including autoimmune diseases, neuropathic pain, liver fibrosis, and cancer. The company utilizes a virtual model for drug development, leveraging in-house expertise alongside global contract research and manufacturing resources to ensure efficient and cost-effective outcomes.
Founded in 2006, Virobay has made significant strides in drug development, including the initiation of several Phase 1 trials for compounds targeting conditions such as neuropathic pain and psoriasis. Their pipeline includes innovative candidates like VBY-036, VBY-891, and VBY-285, which are designed to address critical unmet medical needs across multiple therapeutic areas.
Generated from the website